Implanet SA
PAR:ALIMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Implanet SA
Revenue
Implanet SA
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Implanet SA
PAR:ALIMP
|
Revenue
€12.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
6%
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Revenue
€70.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Biomerieux SA
PAR:BIM
|
Revenue
€4.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Revenue
€5.5m
|
CAGR 3-Years
37%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Revenue
€108.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Revenue
€7.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-4%
|
|
Implanet SA
Glance View
Implanet SA engages in manufacturing implants designed for orthopedic surgery. The company is headquartered in Martillac, Nouvelle-Aquitaine. The company went IPO on 2013-11-25. The company is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The firm's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors, among others. Its activities, and flagship products, include JAZZ (Spine System) and MADISON (Knee implant). JAZZ implant is designed to improve the treatment of spinal pathologies requiring vertebral fusion surgery. MADISON implant is designed for first-line prosthetic knee surgery.
See Also
What is Implanet SA's Revenue?
Revenue
12.5m
EUR
Based on the financial report for Dec 31, 2025, Implanet SA's Revenue amounts to 12.5m EUR.
What is Implanet SA's Revenue growth rate?
Revenue CAGR 10Y
6%
Over the last year, the Revenue growth was 33%. The average annual Revenue growth rates for Implanet SA have been 16% over the past three years , 26% over the past five years , and 6% over the past ten years .
